Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage
See all results for  

dr reddy

Money Control
Hold Dr. Reddy#39;s; target of Rs 4550: Emkay Global Financial
Emkay Global Financial recommended hold rating on Dr. Reddy#39;s with a target price of Rs 4550 in its research report dated July 29, 2020.
 Money Control4 days ago
Money Control
Hold Dr. Reddy#39;s Laboratories; target of Rs 4326: Prabhudas Lilladher
Prabhudas Lilladher recommended Hold rating on Dr. Reddy#39;s Laboratories with a target price of Rs 4326 in its research report dated July 29, 2020.
 Money Control5 days ago
Money Control
Accumulat Dr Reddy#39;s Laboratories; target of Rs 4721: Dolat Capital
Dolat Capital recommended accumulat rating on Dr Reddy#39;s Laboratories with a target price of Rs 4721 in its research report dated July 29, 2020.
 Money Control5 days ago
Ideas For Profit | Why investors with high risk appetite can accumulate Dr Reddy#39;s Laboratories
Watch the video to know if Dr Reddy#39;s meets all the criteria to garner investor interest
 Money Control1 week ago
Trade Spotlight: Dr Reddy’s, IndusInd Bank, Nestle, Maruti and Jubilant Life in focus
Indian market witnessed profit-taking at higher levels on Wednesday and the trend is likely to remain volatile on Thursday as well ahead of June FO expiry.
 Money Control1 week ago
Economic Times
Stocks in the news: Bharti Airtel, Maruti, YES Bank, Dr Reddy's Labs, IndusInd Bank and Nestle India
NIIT Technologies reported a 20.6 per cent drop in profit after tax at Rs 79.9 crore for Q1FY21, while revenue was up 9.8 per cent at Rs 1057 crore. Nifty futures on the Singapore Exchange traded 8.5 points, or 0.08 per cent higher at 11,293, in signs that ...
 Economic Times1 week ago
Economic Times
Dr Reddy's Laboratories gets USFDA nod for Xeglyze lotion, used for lice treatment
Dr Reddy's Laboratories said it is working to commercialise this product through partners. In a regulatory filing, Dr Reddy's Laboratories announced it has received "approval of Xeglyze (abametapir) lotion... by the US Food and Drug Administration (USFDA)".
 Economic Times1 week ago
Money Control
Dr Reddy#39;s Laboratories gets USFDA nod for lice treatment lotion
In September 2015, Dr Reddy#39;s Laboratories had signed a commercialisation deal with Australia#39;s Hatchtech for the latter#39;s prescription head lice product Xeglyze Lotion.
 Money Control1 week ago
Dr Reddy’s gets USFDA nod for Xeglyze lotion
Pharma major Dr Reddy’s Laboratories Ltd has received approval for Xeglyze (abametapir) lotion by the US Food and Drug Administration (USFDA). “The a
 Hindu Business Line1 week ago
Economic Times
Dr. Reddy's firing on all time frames; can hit fresh highs
Trend in Dr Reddy’s Laboratories has been quite strong on all the time frame charts and shown in the chart are the weekly and the daily charts with the Ichimoku indicator. It can be noted on the charts that there is a clear range breakout on both the charts ...
 Economic Times3 weeks ago
Dr Reddy’s launches OTC Nicotine Polacrilex lozenges in US
Dr Reddy’s Laboratories on Tuesday announced the launch of over-the-counter Nicotine Polacrilex lozenges in the American market. The company has lau
 Hindu Business Line3 weeks ago
Money Control
Dr Reddy#39;s Laboratories launches OTC Nicotine Polacrilex lozenges in the US
The product is a store brand version of GlaxoSmithKline Consumer Healthcare LP#39;s Nicorette lozenges, it added.
 Money Control3 weeks ago
Economic Times
Angel Broking has a buy call on Dr Reddy's Labs, target price Rs 4,570
The brokerage believes the acquisition of the domestic business of Wockhardt Pharma is value accretive for the company. ETMarkets.com | Last Updated: Jul 06, 2020, 12.57 PM IST Getty Images Angel Broking has given a buy rating to Dr Reddy's Laboratories with ...
 Economic Times1 month ago
Economic Times
Stocks in the news: Axis Bank, Dr Reddy's Labs, Adani Ports, Hero MotoCorp and Coal India
Uflex has reported a 43.30 per cent rise in consolidated net profit at Rs 100.90 crore for the fourth quarter. ETMarkets.com | Last Updated: Jul 02, 2020, 08.34 AM IST Getty Images Emami Realty's consolidated net loss in March quarter widened to Rs 19.14 ...
 Economic Times1 month ago
Dr Reddy's ties up with Fujifilm, GRA for potential Covid drug
1 2020 09:29:21 PM Hyderabad, Jul 1 (IANS): Pharma major Dr Reddy's Laboratories Ltd on Wednesday announced that it has partnered with Fujifilm Corporation, through Fujifilm Toyama Chemical Co Ltd, and Global Response Aid (GRA) for the development, ...
 Daiji World1 month ago
Economic Times
Dr Reddy's launches generic prostate cancer treatment drug in US
Pharma major Dr Reddy's Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market. PTI | Last Updated: Jun 19, 2020, 05.44 PM IST Agencies Pharma major Dr Reddy's Laboratories on ...
 Economic Times1 month ago
Dr Reddy’s launches cancer drug generic in US
Pharma major Dr Reddy’s Laboratories Ltd has launched abiraterone acetate tablets, a therapeutic equivalent generic version of Zytiga, in the US mark
 Hindu Business Line1 month ago
Dr Reddy’s launches generic fever drug in the US
Pharma major Dr Reddy’s Laboratories Ltd, based in Hyderabad, has launched Colchicine tablets. The drug is a therapeutic equivalent generic version of
 Hindu Business Line1 month ago
Economic Times
Buy Dr. Reddy's Laboratories, target price Rs 4,100: Shrikant Chouhan
The analyst suggested a stoploss at Rs 3,970. ETMarkets.com | Last Updated: Jun 05, 2020, 08.18 AM IST ThinkStock Photos Shrikant Chouhan of Kotak Securities Limited has a buy call on Dr. Reddy's Laboratories Ltd. with a target price of Rs 4100.0. The current ...
 Economic Times2 months ago
Economic Times
Buy Dr Reddy's Laboratories, target price Rs 4,250: Chandan Taparia
The analyst suggested a stoploss at Rs 3980. ETMarkets.com | Last Updated: Jun 01, 2020, 08.29 AM IST ThinkStock Photos Chandan Taparia of Motilal Oswal Securities has a buy call on Dr. Reddy's Laboratories Ltd. with a target price of Rs 4250.0. The current ...
 Economic Times2 months ago
Money Control
Accumulate Dr. Reddy#39;s Laboratories; target of Rs 4326: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Dr. Reddy#39;s Laboratories with a target price of Rs 4326 in its research report dated May 21, 2020.
 Money Control2 months ago
Economic Times
Stock Ideas: Edelweiss has a buy on Dr Reddy’s, target price Rs 4,500
With a focused management, promising complex pipeline and 21% earnings CAGR, the company remains on a strong growth trajectory over FY20–22. ETMarkets.com | Last Updated: May 22, 2020, 01.25 PM IST ThinkStock Photos Company Summary NSE BSE Charts ...
 Economic Times2 months ago
Economic Times
Dr Reddy’s EBITDA has grown much faster than sales: CEO
‘I am optimistic about Dr Reddy’s ability to grow.’ ET Now | Last Updated: May 21, 2020, 03.54 PM IST We did more activities on the same cost structure and that is reflected in the P&L, says Erez Israeli, Chief Executive Officer, Dr Reddy's ...
 Economic Times2 months ago
Economic Times
Brokerages bearish on Dr Reddy’s despite a 76% rise in Q4 profit
k Institutional Equities has retained a ‘sell’ rating on the stock with a price target of Rs 3,100. ETMarkets.com | Last Updated: May 21, 2020, 11.23 AM IST Getty Images Phillip Capital maintained a ‘neutral’ rating on the stock with a target ...
 Economic Times2 months ago
Dr Reddy’s Laboratories launches generic Ocaliva in domestic market
Dr. Reddy’s Laboratories Ltd has launched FXR a therapeutic equivalent generic version of Ocaliva (obeticholic acid) in India.Ocaliva is a trademark
 Hindu Business Line2 months ago
Money Control
In pics | Stock in the news: ICICI Bank, Hero MotoCorp, Apollo Pipes, Dr Lal PathLabs, Lupin, VIP Industries
ICICI Bank, Dr Reddy#39;s Labs, Hero MotoCorp, Sobha, TCI Express, Magma Fincorp and NOCIL are some of the stocks in focus today.
 Money Control2 months ago
Neutral on Dr Reddy's Laboratories, target price Rs 3,410: Haitong Securities
The company received an NDA approval for an anti-migraine drug Elyxyb from the US FDA.
 Economic Times2 months ago
Economic Times
Analyst Calls: RBL Bank, Dr Reddy's Labs
IIFL has a buy rating on RBL Bank with a target price of Rs 190. ET Bureau | Last Updated: May 11, 2020, 06.58 AM IST Getty Images The stock ended down 7.4 per cent at Rs 119.35 on Friday. Company Summary NSE BSE ADD TO PORTFOLIO ADD TO WATCHLIST SHARE YOUR ...
 Economic Times2 months ago
Money Control
Dr Reddy#39;s Laboratories launches generic prostate cancer treatment drug in the US
The company has launched Abiraterone Acetate tablets USP in the strength of 250 mg, after the approval from the United States Food and Drug Administration (USFDA), Dr Reddy#39;s Laboratories said in a filing to the BSE.
 Money Control1 month ago
Dr Reddy's launches generic prostate cancer drug in US
Pharma major Dr Reddy’s Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the
 Hindu Business Line1 month ago
Economic Times
Buy Dr Reddy's Laboratories, target price Rs 4,210: Dharmesh Shah
The analyst suggested a stoploss at Rs 3730. ETMarkets.com | Last Updated: May 26, 2020, 07.57 AM IST ThinkStock Photos Dharmesh Shah of ICICI Direct has a buy call on Dr. Reddy's Laboratories Ltd. with a target price of Rs 4210.0. The current price of Dr.
 Economic Times2 months ago
Money Control
Buy Dr Reddy#39;s Laboratories; target of Rs 4615: ICICI Direct
ICICI Direct is bullish on Dr Reddy#39;s Laboratories has recommended buy rating on the stock with a target price of Rs 4615 in its research report dated May 21, 2020.
 Money Control2 months ago

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Happening by Location Click on any location on map to view latest news by location